Abstract | BACKGROUND: Human immunodeficiency virus (HIV)-related facial lipoatrophy seems to be the most distressing manifestation for individuals with HIV. It can be stigmatizing, severely affecting quality of life and self-esteem. Ever-increasing numbers of individuals with HIV receiving medication for HIV infection are presenting to plastic surgeons and requesting reconstructive surgery to counteract the unwanted side effects of their treatment protocols, for example facial lipoatrophy. The authors show their results with a one-step rehabilitation in cases of facial lipoatrophy using an injectable calcium hydroxylapatite dermal filler mixed with local anesthetic and adrenaline. MATERIALS AND METHODS: RESULTS: No major complications were registered. A stable result was observed in all the cases at the end of follow-up (3 months). High patient satisfaction was achieved in all cases. CONCLUSION:
|
Authors | Raffaele Rauso, Giuseppe Curinga, Antonio Rusciani, Giuseppe Colella, Roberto Amore, Gianpaolo Tartaro |
Journal | Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
(Dermatol Surg)
Vol. 39
Issue 12
Pg. 1887-94
(Dec 2013)
ISSN: 1524-4725 [Electronic] United States |
PMID | 24299576
(Publication Type: Journal Article)
|
Copyright | © 2013 by the American Society for Dermatologic Surgery, Inc. Published by Wiley Periodicals, Inc. |
Chemical References |
- Biocompatible Materials
- Durapatite
|
Topics |
- Adult
- Biocompatible Materials
(administration & dosage, therapeutic use)
- Cosmetic Techniques
- Durapatite
(administration & dosage, therapeutic use)
- Face
- Female
- HIV-Associated Lipodystrophy Syndrome
(drug therapy)
- Humans
- Injections
- Male
- Middle Aged
- Prospective Studies
- Treatment Outcome
|